135 related articles for article (PubMed ID: 23426349)
1. Risk factors for esophageal adenocarcinoma after antireflux surgery.
Löfdahl HE; Lu Y; Lagergren P; Lagergren J
Ann Surg; 2013 Apr; 257(4):579-82. PubMed ID: 23426349
[TBL] [Abstract][Full Text] [Related]
2. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
[TBL] [Abstract][Full Text] [Related]
3. Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux?
Lagergren J; Viklund P
World J Surg; 2007 Mar; 31(3):465-9. PubMed ID: 17171490
[TBL] [Abstract][Full Text] [Related]
4. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
Wu AH; Tseng CC; Bernstein L
Cancer; 2003 Sep; 98(5):940-8. PubMed ID: 12942560
[TBL] [Abstract][Full Text] [Related]
5. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249
[TBL] [Abstract][Full Text] [Related]
6. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.
Lindblad M; Rodríguez LA; Lagergren J
Cancer Causes Control; 2005 Apr; 16(3):285-94. PubMed ID: 15947880
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma.
Lagergren J; Mattsson F; Nyrén O
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):45-51. PubMed ID: 23920035
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.
Whiteman DC; Sadeghi S; Pandeya N; Smithers BM; Gotley DC; Bain CJ; Webb PM; Green AC;
Gut; 2008 Feb; 57(2):173-80. PubMed ID: 17932103
[TBL] [Abstract][Full Text] [Related]
9. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
Corey KE; Schmitz SM; Shaheen NJ
Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
[TBL] [Abstract][Full Text] [Related]
10. Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
Maret-Ouda J; Konings P; Lagergren J; Brusselaers N
Ann Surg; 2016 Feb; 263(2):251-7. PubMed ID: 26501714
[TBL] [Abstract][Full Text] [Related]
11. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.
Ye W; Chow WH; Lagergren J; Yin L; Nyrén O
Gastroenterology; 2001 Dec; 121(6):1286-93. PubMed ID: 11729107
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Lagergren J; Bergström R; Lindgren A; Nyrén O
N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
[TBL] [Abstract][Full Text] [Related]
13. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study.
Tran T; Spechler SJ; Richardson P; El-Serag HB
Am J Gastroenterol; 2005 May; 100(5):1002-8. PubMed ID: 15842570
[TBL] [Abstract][Full Text] [Related]
14. Poor outcome of oesophageal adenocarcinoma after prior antireflux surgery.
Mitchell EM; Pal N; Kalyan JP; Rhodes M; Lewis MP
Int J Surg; 2009 Dec; 7(6):566-9. PubMed ID: 19833239
[TBL] [Abstract][Full Text] [Related]
15. [Alarming increase of esophageal cancer. Is antireflux surgery an efficient prevention?].
Lundell L
Lakartidningen; 2000 Dec; 97(51-52):6016-20. PubMed ID: 11195438
[No Abstract] [Full Text] [Related]
16. [Can antireflux surgery prevent malignant degeneration of Barrett esophagus?].
Hölscher AH; Bader M; Siewert JR
Dtsch Med Wochenschr; 1985 Apr; 110(14):551-5. PubMed ID: 3979294
[No Abstract] [Full Text] [Related]
17. The risk of esophageal adenocarcinoma after antireflux surgery.
Lagergren J; Ye W; Lagergren P; Lu Y
Gastroenterology; 2010 Apr; 138(4):1297-301. PubMed ID: 20080091
[TBL] [Abstract][Full Text] [Related]
18. Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study.
Jansson C; Johansson AL; Nyrén O; Lagergren J
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1754-61. PubMed ID: 16030113
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
Spechler SJ; Lee E; Ahnen D; Goyal RK; Hirano I; Ramirez F; Raufman JP; Sampliner R; Schnell T; Sontag S; Vlahcevic ZR; Young R; Williford W
JAMA; 2001 May; 285(18):2331-8. PubMed ID: 11343480
[TBL] [Abstract][Full Text] [Related]
20. [Increased incidence of adenocarcinoma of the esophagus and cardia. Reflux and obesity are strong and independent risk factors according to the SECC study].
Lagergren J
Lakartidningen; 2000 Apr; 97(16):1950-3. PubMed ID: 10826353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
